期刊
FREE RADICAL BIOLOGY AND MEDICINE
卷 51, 期 3, 页码 780-790出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2011.05.019
关键词
Radioprotection; Redox imaging; Blood-brain-barrier-permeable contrast agents; Nitroxides; Magnetic resonance imaging
资金
- NIAID
- Center of Cancer Research, National Cancer Institute, NIH
Individuals are exposed to ionizing radiation during medical procedures and nuclear disasters, and this exposure can be carcinogenic, toxic, and sometimes fatal. Drugs that protect individuals from the adverse effects of radiation may therefore be valuable countermeasures against the health risks of exposure. In the current study, the LD50/30 (the dose resulting in 50% of exposed mice surviving 30 days after exposure) was determined in control C3H mice and mice treated with the nitroxide radioprotectors Tempol, 3-CP, 16c, 22c, and 23c. The pharmacokinetics of 22c and 23c were measured with magnetic resonance imaging (MRI) in the brain, blood, submandibular salivary gland, liver, muscle, tongue, and myocardium. It was found that 23c was the most effective radioprotector of the five studied: 23c increased the LD50/30 in mice from 7.9 +/- 0.15 Gy (treated with saline) to 11.47 +/- 0.13 Gy (an increase of 45%). Additionally, MRI-based pharmacokinetic studies revealed that 23c is an effective redox imaging agent in the mouse brain, and that 23c may allow functional imaging of the myocardium. The data in this report suggest that 23c is currently the most potent known nitroxide radioprotector, and that it may also be useful as a contrast agent for functional imaging. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据